Search results
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Morningstar· 1 day agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1 ...
Invivyd appoints two new directors to its board By Investing.com
Investing.com· 2 days agoInvivyd Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced the election of two new...
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
KTLA-TV Los Angeles· 6 hours agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted...
Nutraingredients.com· 4 days agoNumerous studies have shown how the coronavirus infection can cause medium and long-term effects, generally known as “chronic COVID syndrome” or “Long-COVID”. One of the most common symptoms ...
Iran's new president's link to COVID vaccine
Newsweek· 4 days agoNew interim Iranian President Mohammad Mokhber received scrutiny for his role in the lack of development of a domestic vaccine at the height of the...
What to Know: FLiRT COVID-19 Variants Spreading in the U.S.
US News & World Report· 4 days agoA group of COVID-19 variants nicknamed “FLiRT” is spreading as the U.S. heads into summer. JN.1 was the top strain circulating in the U.S. for much of the winter. KP.2 was ...
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
Morningstar· 1 day agoSHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it ...
How a simulation is informing COVID-19 vaccine policy after our 'return to normal'
Medical Xpress· 4 days agoBefore the emergence of the omicron COVID-19 variant, countries like the U.K. had high vaccination...
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and...
The Yuma Sun· 4 days agoThe efficacy of ARCT-154 against severe COVID...
Mask Myth Busted? New Research Reveals That Wearing Face Masks Did Not Reduce Risk of COVID...
SciTechDaily· 5 days agoA new study indicates that face masks did not significantly lower Covid-19 infection risk after the initial Omicron wave, highlighting the need for adaptable strategies and further research ...